Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03087955Phase 2/3Completed
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
Gambiense TrypanosomiasisSleeping SicknessTrypanosomiasis, African
PrincipalinvestigatorStart date: 2016-10-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ministère de la Santé, The Democratic Republic of the Congo

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Enock Matovu, Prof

Makerere University

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Raquel Inocencio da Luz, PhD

Institute of Tropical Medicine

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Digas Ngolo Tete, MPH

National HAT Control Programme, Kinshasa, The Democratic Republic of the Congo

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Mamadou Camara, PhD

National HAT Control Programme, Conakry, Guinea

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Médard Ilunga Wa Kyhi, MD

National HAT Control Programme, Kinshasa, The Democratic Republic of the Congo

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Kumeso, MD

Ministry of Health, Kinshasa, The Democratic Republic of the Congo

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Ku Mesu, Dr

Ministry of Public Health, Hygiene and Prevention, Kinshasa

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Victor Kande Betu Kumeso, Dr.

Ministry of Public Health, Hygiene and Prevention, Kinshasa

Related
1 trials

Shared therapeutic areas:

Sleeping SicknessTrypanosomiasis, African

Worked with same sponsors:

Drugs for Neglected Diseases
Similarity Score20%

Veerle Lejon, PhD, HDR

Institut de Rechercher pour le Développement

Related
1 trials

Shared therapeutic areas:

Trypanosomiasis, AfricanSleeping Sickness
Similarity Score20%

Veerle Lejon, PhD

Institut de Recherche pour le Developpement

Related
2 trials

Shared therapeutic areas:

Trypanosomiasis, African
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03087955Phase 2/3PrincipalInvestigator

Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense

Gambiense TrypanosomiasisSleeping SicknessTrypanosomiasis, African
Completed

All 1 trials loaded